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Basal cell carcinoma (BCC) is the most common type of skin
malignancy [1,2]. It occurs most frequently in areas of the
body that receive elevated levels of sun exposure. There are
some covered areas, however, such as the breast, the axilla,
the groin, the palm, the thigh, the genital and perineal
region that have also been reported as uncommon sites of
BCC [3,4]. BCC of the nipple-areola complex is very rare,
with only 24 cases reported in the literature [5–7]. We report
on a case of BCC of the nipple-areola complex, in a 46-year-
old woman treated with partial mastectomy and excision of
sentinel lymph node.
CASE PRESENTATION
A 46-year-old woman complained of a slightly crusted,
well-defined plaque (roughly  2 = 1 cm) with pruritus in the
medial upper portion of the areola of her right breast.
She reported feeling gradual growth of the plaque over
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several years. She had no previous or family history of skin
cancer and no history of sunbathing, radiation, or arsenic
exposure. She also had no history of previous surgery,
trauma, or pre-existing disease of her right breast, and her
medical history did not reveal any possible contributing
factors. Her breast sonogram and mammogram were
normal.
We first excised the plaque in May 2004, and a
diagnosis of BCC, superficial subtype, was made (Figure
1). Because the resection margin was not free of tumor
cells, we later performed a partial mastectomy  with an
excision of a sentinel lymph node of the right axilla
(Figure 2). As reactive hyperplasia of the sentinel lymph
node was noted by a pathologic report, radical dissection
of axillary lymph node was not performed. The pathologic
report presented a focal residual BCC in the papillary
dermis, but the resection margins were free of tumor cell
involvement. No recurrence was noted after a 1-year
follow-up.
DISCUSSION
The most significant risk factors for BCC are ultraviolet
(UV) light and radiation exposure [8,9]. Therefore, BCC
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typically occurs in the sun-exposed areas of the body. While
BCC of the breast is not unusual, BCC of the nipple-areola
complex is an uncommon pathologic condition. Robinson
reported the first case of a rodent ulcer of the male breast in
a 60-year-old man in 1893 [10]. Only 24 such cases have
since been reported in the literature [5–7]. The reported
patients ranged between 39 and 80 years of age. Of these 24
cases, 17 were male, as the tendency for this area of the body
to receive direct sunlight is greater in men than in women.
Other risk factors for BCC may include previous history
of BCC, family history of BCC, basal cell nevus (Gorlin’s)
syndrome, and a tendency to sunburn [7,11,12]. Our patient
had none of these risk factors and denied any history of
direct UV exposure to the nipple-areola complex.
Clinical presentations of these lesions have varied
from erythematous, scaling, eczematous cutaneous lesions
to frankly ulcerating and subareolar masses [13,14]. Our
case presented a slightly crusted, well-defined plaque
(roughly 2 = 1 cm), with pruritus in the medial upper
portion of the areola of her right breast. Differential
diagnoses of erythematous, scaling lesion, of the nipple-
areola complex included contact dermatitis, Paget’s
disease, BCC, Bowen’s disease, and erosive adenomatosis
[7]. Because the treatment and prognosis of these diseases
are very different, it is very important to make an accurate
diagnosis.
The estimated incidence of metastasis for BCC is less
than 0.025 % [15]. However, metastasis to the axillary
lymph nodes had been noted in 3 (12.5%) of the 24 reported
cases of BCC of the nipple-areola complex. This fact
indicates a higher malignant potential for tumors in this
location, due to the rich network of lymphatic capillaries
in the subareolar plexus [13,16,17]. This anatomically
distinct lymphatic plexus originates in the dermis of the
nipple-areola complex, and terminates in the regional
lymph nodes. This termination may potentially provide a
direct pathway for tumor spread [5]. Another possible
explanation of the pathway suggests a propensity of BCC
of the nipple-areola complex to invade underlying
lactiferous ducts. When the tumors of BCC involve the
lactiferous ducts, they may potentially invade the deep
soft tissue. However, BCC of other areas of the body does
not usually invade the underlying soft tissue. Invasion
into deep soft tissue may increase the chance of metastasis
of BCC of the nipple-areola complex.
The treatment for BCC of the nipple-areola complex
depends on the extent of the tumor and on the possible
involvement between the nipple-areola complex and
mammary tissue. While the majority of the reported cases
Figure 1. Section showing several lobules of neoplastic basaloid cells at
the dermoepidermal region. Peripheral nuclear palisading and separation
artifact can be clearly seen (hematoxylin & eosin, =100).
Figure 2. Partial mastectomy. (A) surgical specimen, excision scar
(white arrow), (B) operation wound 1 year after operation.
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of BCC of the nipple-areola complex were treated with
simple excision, postoperative radiotherapy was also given
as a prophylactic measure in some cases. Several reported
cases of nipple-areola complex were treated with
mastectomy as the first line of therapy and without
adjunctive treatment [16–19].
One of the reported patients was treated with retinoids,
and treated with mastectomy after a new breast lump was
detected [20]. Moh’s surgery, also called Moh’s micrographic
surgery (MMS), is a precise surgical technique that removes
all parts of cancerous skin tumors while preserving as much
healthy tissue as possible. MMS was used to treat several
reported cases of BCC of the nipple-areola complex. For our
case, because a free surgical margin was not obtained at the
first excision operation, we chose partial mastectomy with
adequate free margin as the appropriate treatment. While
metastasis to axillary lymph nodes had been reported in
three previously reported cases, BCCs of the nipple-areola
complex are not thought to have a different or greater
malignant potential than other BCCs [5,6].
We applied the concept of the sentinel lymph node to
detect the possible metastasis of axillary lymph nodes, and
to avoid unnecessary axillary lymph node dissection and
possible morbidity. This is the first report of the application
of the sentinel lymph node concept in the treatment of BCC
of the nipple-areola complex.
In conclusion, making an accurate diagnosis of any
cutaneous lesions of the nipple-areola complex is essential.
If the diagnosis of BCC is made, aggressive treatments,
including simple excision, MMS or mastectomy, are
strongly indicated to minimize the risk of recurrence.
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